Home/Healthcare/Rare Diseases/Global Heart Failure Market

Global Heart Failure Market - Strategic Insights and Forecasts (2026-2031)

Market Size, Share, Forecasts and Trends Analysis By Therapy Type (Pharmacological Therapies, Medical Devices, Surgical Interventions, Digital Therapeutics and Monitoring), By Drug Class (ARNIs, SGLT2 Inhibitors, Beta Blockers, ACE Inhibitors, ARBs, MRAs, Diuretics, Vasodilators, Others), By Indication (HFrEF, HFpEF, HFmrEF, Acute Heart Failure, Chronic Heart Failure), By Route of Administration (Oral, Intravenous, Implantable/Device-Based), By End User (Hospitals, Specialty Cardiology Clinics, Ambulatory Surgical Centers, Home Care Settings), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Pharmacies), and Geography

$3,950
Single User License
Access Full Insights
Report OverviewSegmentationTable of ContentsCustomize Report

Request Customization

Tell us your specific requirements and we will customize this report for you.

📞

Your data is secure. We do not share information with any third party.

Global Heart Failure Market Report

Report IDKSI-008716
PublishedJun 2026
Pages154
FormatPDF, Excel, PPT, Dashboard

Need Assistance?

Our research team is available to answer your questions.

Contact Us
Frequently Asked Questions

The global heart failure market is expected to grow from USD 26.8 billion in 2026 to USD 38.5 billion by 2031, registering a CAGR of 7.5%.

Major growth drivers include rising aging populations, increasing diabetes prevalence, growing adoption of guideline-directed therapies, expansion of remote monitoring technologies, and broader treatment approvals for HFpEF.

AI is increasingly used in predictive cardiac monitoring, data analytics, and early detection systems to support preventive intervention and continuous disease management.

Key restraints include high branded drug costs, treatment adherence challenges, complex comorbidity management, and shortages of cardiology specialists in emerging markets.

North America leads the market due to advanced cardiovascular infrastructure, strong reimbursement systems, and high adoption of innovative therapies and monitoring technologies.

Need data specifically for your business?Request Custom Research →

Trusted by the world's leading organizations

Weber Shandwick
veolia
Tri
tls
TeamViewer
GE Healthcare
Intel
Proctor and Gamble
ABB
Elkem
Defense Logistics Agency
Amazon